Ladiratuzumab Antibody
Ladiratuzumab (hLIV22) is a humanized monoclonal antibody targeting the LIV-1 (ZIP6) protein. It serves as the naked antibody component for the antibody-drug conjugate SGN-LIV1A and is used in research for the study and potential treatment of breast cancer, with applications in both in vitro and in vivo experimental models.
Product Specifications
Product Name Alternative
HLIV22, Ladiratuzumab
Target
ADC Antibody, Others
Clonality
Monoclonal
Conjugation
Unconjugated
Concentration
3.12 mg/mL
Purity
>95% (May vary between batches)
Molecular Weight
146.1 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC400225-500 1x 500 µL
Major Vault Protein (MVP) (1032), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC680177-100 1x 100 µL
CD50 (ICAM-3) (101-1D2), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040257-500 1x 500 µL
Cytokeratin, HMW (AE-3), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC740177-100 1x 100 µL
CD50 (ICAM-3) (101-1D2), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC742216-500 1x 500 µL
CD50 / ICAM3 (CG106), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details